Health
Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack – News-Medical.Net
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to…
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme(ACE)inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiologys 70thAnnual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure…
-
General5 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoBrisbane’s original 1979 electric trains take one last journey
-
Noosa News14 hours agoRainbow Beach surfer’s untold 7/7 story
-
General21 hours agoParis opens River Seine for public swimming for first time since 1923